Exemplis Discimus 2002, 146(2):59-61

Aenean turpis sapien, elementum at, pellentesque ut, viverra eget, ligula..

Tover Staven, Hadji Dane, Senesha Charrel, Ordol Keithel, Banbl Narson
1st Clinic of Gastroenterology, Teaching Hospital of Braxant, Republic of Kessel
National Institute of Forensic Medicine, Auril Teaching Hospital, Endor Republic

Praesent at augue porttitor pede pellentesque porta. Quisque purus ante, luctus eget, tincidunt et, dapibus sit amet, lacus. Nulla odio nisi, interdum non, mollis at, feugiat at, ligula. Aenean quis turpis a mauris fermentum vulputate. Nam pede leo, ornare ac, porta quis, dignissim sit amet, erat. Fusce pede lorem, lobortis ac, blandit sed, condimentum eget, est. Aliquam ipsum lorem, consectetuer vitae, scelerisque sit amet, ultricies ac, risus. Nunc ut tellus vitae lectus tempor facilisis.

Klíčová slova: Vivamus porta, Vestibulum magna

Vloženo: 20. září 2002; Zveřejněno: 1. prosinec 2002 

Zobrazit celý článek

Reference

  1. Abildgaard N, Nielsen JL, Heickendorf L (1994) Connective tissue components in serum in multiple myeloma: analyses of propeptides of type I and type III procollagens, type I collagen telopeptide and hyaluronan. American Journal of Hematology 46, 173-178. DOI: 10.1002/ajh.2830460303 Přejít k původnímu zdroji... Přejít na PubMed...
  2. Abildgaaard N, Bentzen SM, Nielsen JL, Heickendorff L (1997) Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen. Br J Haematol 96 (1), 103-10. DOI: 10.1046/j.1365-2141.1997.8672495.x Přejít k původnímu zdroji... Přejít na PubMed...
  3. Blomquist C, Risteli L, Risteli J. (1999) Markers of type I collagen degradation and synthesis in monitoring of treatment response in bone metastases from breast carcinoma. Br J Cancer, 73 (9), 1074-9. Přejít k původnímu zdroji...
  4. Carlson K, Larsson A, Simonson B, et al. (1999) Evaluation of bone disease in multiple myeloma a comparison between the resorption markers urinary deoxypyridinoline / creatinine (DPD) and serum ICTP, and an evaluation of DPD / osteocalcin and ICTP /osteocalcin ratios. Eur J Haematol, 62 (5), 300-6. Přejít k původnímu zdroji...
  5. Fonseca R, Trendle MC, Leong T, Kyle RA, et al. (2000) Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patients. Br J Haematol, 109 (1), 249. Přejít k původnímu zdroji...
  6. Risteli J, Elomaa I, Niemi S, et al. (1993) Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: new serum marker of bone collagen degradation. Clin Chem 39 (4), 635-40. Přejít na PubMed...
  7. Tanaka K, Shiraishi K, et al. (1998) Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia. Rinsho Ketsueki, 39 (4), 273-80.

Zpět na obsah